<DOC>
	<DOCNO>NCT00292344</DOCNO>
	<brief_summary>Most case traveler ' diarrhea cause bacterial pathogen respond slowly antibiotic treatment.The study design determine value rapidly act loperamide ( imodium ) combine curative dose poorly absorb rifaximin traveler ' diarreha treatment .</brief_summary>
	<brief_title>Rifaximin , Loperamide Combination Treat Travelers ' Diarrhea</brief_title>
	<detailed_description>During short-term study , adult U.S. student Mexico ( n = 310 ) acute diarrhea ( â‰¥ 3 unformed stool enteric symptom ) enrol double-blind , randomize trial wherein give rifaximin 200 mg three time day 3 day ( R ) ( n = 102 ) , loperamide 4 mg initially follow 2 mg unformed stool exceed 8 mg/day 2 day ( L ) ( n = 104 ) drug dosage schedule ( L/R ) ( n = 104 ) . The major outcome parameter time initiation therapy passage last unformed stool become well ( TLUS ) .</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Dysentery</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<mesh_term>Loperamide</mesh_term>
	<mesh_term>Antidiarrheals</mesh_term>
	<criteria>Inclusion criterion include : IRB approval ; sign consent form ; 18 year age old , provide unformed pretreatment stool ; female must nonpregnant nursing . Exclusion criterion include : diarrhea longer 72 hour ; moderate severe dehydration , pregnancy breast feeding , receipt trimethoprimsulfamethoxazole , azalide , doxycycline , fluoroquinolone past week ; unstable medical condition ; hypersensitivity rifaximin rifampin ; fever ( &gt; 100.6o F ) bloody diarrhea .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2006</verification_date>
	<keyword>Travelers ' diarrhea</keyword>
	<keyword>rifaximin</keyword>
	<keyword>loperamide</keyword>
	<keyword>enterotoxigenic E. coli</keyword>
</DOC>